Evidence Hierarchy in Genetic Medicine: Methodology Review

Critical analysis of research methodology in genetic medicine. Evaluating evidence quality standards for molecular diagnostics and gene therapy.

When Methodology Matters More Than Results: Analyzing Contemporary Research Through the Lens of Evidence Hierarchy in Genetic Medicine When Methodology Matters More Than Results: Analyzing Contemporary Research Through the Lens of Evidence Hierarchy in Genetic Medicine Contemporary genetic medicine is experiencing a paradoxical moment in its development. On one hand, we observe exponential growth in the number of publications claiming breakthrough discoveries in molecular diagnostics, gene therapy, and personalized medicine. On the other hand, critical analysis of the methodology of these studies reveals systematic problems that call into question the validity of many conclusions. The problem is compounded by the fact that the scientific community and medical regulators have still not developed unified standards for assessing the quality of evidence for innovative technologies at the intersection of fundamental science and clinical practice. The set of publications presented for analysis demonstrates a wide spectrum of methodological approaches—from rigorous experimental studies to machine learning and technological innovations. Notably, none of the reviewed works directly relates to clinical genetics in the traditional sense; however, each illustrates critically important aspects of scientific methodology applicable to the evaluation of genetic research. This allows for a meta-analysis not of specific genetic data, but of the very principles of obtaining, validating, and interpreting scientific evidence in modern biomedicine. The retraction of an article by PLOS One editors, included in the list of sources, serves as a starting point for discussing a fundamental question: how often do published results turn out to be irreproducible or methodologically unsound? According to a meta-analysis by Ioannidis (2005), published in PLOS Medicine, more than half of published research findings may be false due to methodological errors, conflicts of interest, and the pursuit of statistically significant results. In genetics, this problem is particularly relevant, given the complexity of analyzing multifactorial interactions and the high risk of false-positive associations in multiple testing. The hierarchy of evidence, developed for clinical medicine, traditionally places systematic reviews of randomized controlled trials at the top of the pyramid, and expert opinion and case descriptions at the base. However, when applied to genetic research, this hierarchy requires substantial modification. Genome-wide association studies (GWAS), exome sequencing, functional validation of variants—each of these approaches requires its own criteria for assessing evidence quality. Moreover, many genetic findings are obtained in animal models or cell cultures, creating an additional level of uncertainty when extrapolating to humans. The work by Ortega-Fimbres on analyzing cortical dysplasias using diffusion MRI in animal models represents just such a case. The study methodology reflects contemporary approaches to imaging structural brain anomalies, which often have a genetic nature. Cortical dysplasias are a heterogeneous group of cortical development disorders associated with mutations in genes of the mTOR signaling pathway, including TSC1, TSC2, DEPDC5, NPRL2, NPRL3. However, transferring data obtained from animal models to human populations requires multi-step validation, which is rarely conducted with due rigor. The work by Mizuhara, using machine learning to identify researcher characteristics, demonstrates another methodological challenge of modern science. Machine learning algorithms are increasingly applied to analyze genomic data, predict pathogenicity of genetic variants, and stratify risks. However, the "black box" of many algorithms creates a problem of result interpretability. How can one assess the quality of evidence obtained using a neural network that cannot explain the logic of its predictions? This introductory analysis sets before us the task of systematically evaluating the methodological approaches presented in various fields of science and extrapolating the identified principles to the field of genetic medicine. It is necessary to determine which validity criteria are applicable to different types of research, how to identify systematic errors and biases, and what is necessary for genetic findings to transform into clinically significant recommendations. Methodological Rigor in Experimental Research: Lessons from Unexpected Fields The study by Sitthikitpanya, devoted to the resilience of anaerobic digestion to contamination by polypropylene microplastics, at first glance has no relation to genetic medicine. However, detailed analysis of this work's methodology reveals principles of experimental design critically important for any biomedical research, including the study of genetic mechanisms of diseases. The main strength of this study lies in systematic kinetic analysis of the process with control of multiple parameters. The authors evaluated the effect of various concentrations of polypropylene microplastics (from 0 to 5 g/L) on the rate and efficiency of anaerobic digestion, measuring methane production, changes in microbial community structure, and physicochemical parameters of the process. Such a multi-parametric approach is necessary in genetic research as well, where phenotypic manifestations of mutations often depend on multiple factors—genetic background, epigenetic modifications, environmental factors. A critically important aspect of the work is the use of time series with multiple measurement points. The authors did not limit themselves to evaluating the endpoint but traced the dynamics of changes throughout the entire process. In genetic research, an analogous approach means the need for prospective observation of carriers of genetic variants, not just retrospective case-control analysis. Prospective cohort studies occupy a higher position in the evidence hierarchy precisely becaus…
All research articles Research digest Physician article feed